stockrow
Friday 6 November 2026
Export BHVN’s income statement to Excel — free account
Biohaven Ltd.
BHVN Healthcare Biotechnology
- EPS
- +47.8%
- Free cash flow
- +26.6%
- Total debt
- −1.48%
Quarter to September 2026, against a year earlier
14.41
0.51
+3.67%
Follow BHVN
Alert me
Biohaven Ltd. (BHVN) Operating cash flow
Biohaven Ltd.'s operating cash flow for fiscal 2025 was −$609.4M, compared with −$582.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$472.5M. Over the past ten years it has ranged from −$609.4M (fiscal 2025) to −$5.6M (fiscal 2015) — the current reading is the lowest in ten years. Operating cash flow has fallen for 5 consecutive fiscal years. Biohaven Ltd. ranks 593rd of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$609.4M | — |
| FY2024 | −$582.5M | — |
| FY2023 | −$331.7M | — |
| FY2022 | −$297.7M | — |
| FY2021 | −$145.8M | — |
| FY2020 | −$76.0M | — |
| FY2019 | −$377.3M | — |
| FY2018 | −$197.1M | — |
| FY2017 | −$94.8M | — |
| FY2016 | −$29.5M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | −$106.9M | — |
| Jun 2026 | −$85.1M | — |
| Mar 2026 | −$149.9M | — |
| Dec 2025 | −$130.7M | — |
| 40 more quarters | Free account |
Against its own ten years
Low −$609.4M
High −$5.6M
Ten-year median
−$197.1M
Current reading's percentile
9
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| AUPH Aurinia Pharmaceuticals Inc compare | $177.2M |
| ADMA ADMA Biologics Inc compare | $140.8M |
| VCEL Vericel Corporation compare | $65.3M |
| PVLA Palvella Therapeutics, Inc. compare | −$36.5M |
| IMNM Immunome, Inc. compare | −$208.8M |
| CLDX Celldex Therapeutics, Inc. compare | −$235.6M |
| VERA Vera Therapeutics, Inc. compare | −$338.7M |
| BHVN Biohaven Ltd. | −$472.5M |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | −$508.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item